PMID- 17459645 OWN - NLM STAT- MEDLINE DCOM- 20071003 LR - 20131121 IS - 0731-7085 (Print) IS - 0731-7085 (Linking) VI - 44 IP - 3 DP - 2007 Jul 27 TI - High-performance liquid chromatographic determination and pharmacokinetic study of vitexin-2''-O-rhamnoside in rat plasma after intravenous administration. PG - 802-6 AB - A simple and specific high-performance liquid chromatographic (HPLC) method was developed for the pharmacokinetic study of vitexin-2''-O-rhamnoside (VOR) in rat after intravenous administration. The plasma samples were deproteinized with methanol after addition of internal standard (i.s.) hesperidin. HPLC analysis was performed on a Diamonsil ODS C18 analytical column, using acetonitrile-0.3% formic acid (20:80, v/v) as the mobile phase with UV detection at 270 nm. The standard curve was linear over the range of 0.1070-21.41 microg/mL in rat plasma. The average extraction recovery of VOR was 97.9+/-3.1%, and the relative standard deviations (R.S.D.s) of the intra- and inter-day precisions were no more than 7.4 and 8.5%, respectively. The lower limit of quantification (LLOQ) was 0.1070 microg/mL. The AUC of VOR was proportional to the dose after intravenous administration of 15, 30, 60 and 120 mg/kg body weight, and the elimination half-life (t1/2beta), systemic clearance (Cl) and apparent volume of distribution (Vc) were not significantly different among the four doses, and all the results indicated that the pharmacokinetics of VOR in rat obeyed first-order kinetics. FAU - Ying, Xixiang AU - Ying X AD - School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning Province 110016, PR China. FAU - Gao, Shuo AU - Gao S FAU - Zhu, Wenliang AU - Zhu W FAU - Bi, Yujin AU - Bi Y FAU - Qin, Feng AU - Qin F FAU - Li, Xiaoqin AU - Li X FAU - Li, Famei AU - Li F LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20070324 PL - England TA - J Pharm Biomed Anal JT - Journal of pharmaceutical and biomedical analysis JID - 8309336 RN - 0 (Plant Extracts) RN - 32426-34-9 (vitexin rhamnoside) RN - 7V515PI7F6 (Apigenin) RN - E750O06Y6O (Hesperidin) SB - IM MH - Animals MH - Apigenin/administration & dosage/blood/chemistry/*pharmacokinetics MH - Area Under Curve MH - Calibration MH - Chromatography, High Pressure Liquid/instrumentation/*methods MH - Crataegus/chemistry MH - Dose-Response Relationship, Drug MH - Drug Stability MH - Freezing MH - Half-Life MH - Hesperidin/chemistry MH - Injections, Intravenous MH - Male MH - Metabolic Clearance Rate MH - Molecular Structure MH - Plant Extracts/chemistry MH - Plant Leaves/chemistry MH - Rats MH - Rats, Wistar MH - Reference Standards MH - Reproducibility of Results MH - Sensitivity and Specificity MH - Temperature MH - Time Factors EDAT- 2007/04/27 09:00 MHDA- 2007/10/04 09:00 CRDT- 2007/04/27 09:00 PHST- 2006/11/13 00:00 [received] PHST- 2007/03/10 00:00 [revised] PHST- 2007/03/16 00:00 [accepted] PHST- 2007/04/27 09:00 [pubmed] PHST- 2007/10/04 09:00 [medline] PHST- 2007/04/27 09:00 [entrez] AID - S0731-7085(07)00182-3 [pii] AID - 10.1016/j.jpba.2007.03.015 [doi] PST - ppublish SO - J Pharm Biomed Anal. 2007 Jul 27;44(3):802-6. doi: 10.1016/j.jpba.2007.03.015. Epub 2007 Mar 24.